Home > Salute > CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Lead... CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U. ... di Redazione Notizie.it Pubblicato il 30 Gennaio 2020